Aksigen IVF Expands Science-led Fertility Care with New Integrated Centre in Panvel

▴ Aksigen IVF
New 5,000 sq. ft. centre brings advanced embryology, AI-enabled diagnostics, RFID-based embryo witnessing, evidence-based clinical pathways and an immersive IVF Knowledge Centre to Navi Mumbai.

Mumbai, 11 September 2026: Aksigen IVF today announced the launch of its new 5,000 sq. ft. fertility centre in Panvel, Maharashtra, marking another step in expanding access to quality fertility care across Navi Mumbai, Raigad and neighbouring regions.

 

The new centre reflects Aksigen IVF's science-led model of fertility care, bringing together advanced embryology, full diagnostic services, personalised clinical pathways, digital laboratory systems and patient education under one roof. Designed around quality, transparency and clinical governance, the centre aims to expand access to evidence-based fertility care across Navi Mumbai, Raigad and neighbouring regions.

 

A key highlight of the Panvel centre is the Bharat Daftary Knowledge Centre (BDKC), the first of its kind immersive IVF Knowledge Centre, in Navi Mumbai & Raigad region ,designed to help patients understand fertility, IVF treatment and reproductive health through interactive and technology-enabled learning experiences.

 

The Panvel centre offers fertility consultations and advanced diagnostic services, supported by an advanced embryology laboratory at its core. Designed with a strong emphasis on precision, consistency and patient safety, the laboratory operates within rigorously validated environmental controls and follows SOP-driven workflows. This ensures high standards of quality and reliability across every stage of the IVF journey, including fertilisation, embryo culture and cryopreservation. The centre provides a full range of assisted reproductive technologies, including In Vitro Fertilisation (IVF), Intracytoplasmic Sperm Injection (ICSI), Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Preimplantation Genetic Testing (PGT/PGD), Laser Assisted Hatching, advanced embryo culture and cryopreservation.

 

The centre is also equipped with the LensHooke CASA X12 Pro, an AI-enabled semen analysis platform capable of assessing double strand DNA Fragmentation Index (DFI), providing objective and reproducible semen analysis that provides deeper insights into male fertility to support informed treatment planning. 

 

To further strengthen patient safety, the centre has implemented RFID-based electronic witnessing with biometric verification, enabling complete traceability of biological samples throughout the IVF journey. Combined with manual double witnessing and digital documentation, the system enhances transparency while supporting chain-of-custody protocols. The Panvel centre incorporates key elements of Aksigen IVF's proprietary ROOTS 360 ecosystem, integrating advanced embryology, AI-enabled clinical governance, personalised treatment pathways, digitally integrated electronic medical records (EMR) and ANIRA, Aksigen IVF's digital fertility companion, to deliver a connected and patient-centric care experience.

 

Speaking on the launch, Dr. Gautam Daftary Founder, Chairman and Managing Director, Aksigen IVF said, "Expanding into Panvel is about making high-quality fertility care more accessible to families across Navi Mumbai and surrounding regions. We have brought consultations, diagnostics, embryology, treatment and patient education together under one roof, supported by advanced technology and clinical systems. As we continue to grow, our focus remains on delivering consistent, transparent and patient-centred fertility care."

 

Highlighting the centre's clinical approach, Dr. Varsha Patial, Centre Head, Aksigen IVF added, "Successful fertility treatment is built on much more than technology. It requires consistent laboratory quality, evidence-based clinical pathways and informed patients. By bringing these elements together, we are able to personalise treatment while maintaining the highest standards of quality, consistency and patient safety throughout the care journey."

 

The Panvel centre further strengthens Aksigen IVF's award-winning clinic network while reinforcing its commitment to combining clinical expertise, technology and patient education to improve the fertility care experience and treatment outcomes.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026